GENE ONLINE|News &
Opinion
Blog

Reed Slater

WRITTEN BY Reed Slater

Sosei Heptares and Abbvie Partner in Potential $1.2 Billion Neurological Disease Deal
2022-08-02
DeepMind’s AlphaFold Predicts Over 200 Million Protein Shapes in AI Breakthrough
2022-08-01
BD, CerTest Commercialize Research-Use Monkeypox Test Amidst Rising Cases
2022-07-29
The Marburg Virus Strikes Again in Africa, Prompting the World to Stay Alert
2022-07-28
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
2022-07-28
3M Creates $1 Billion Trust in Attempt to Resolve Military Earplug Lawsuit
2022-07-27
CK Life Sciences and CK Hutchison Invest in Taiwanese Liquid Biopsy Candidate
2022-07-26
Innovating Drug Delivery Systems with Moderna’s Bob Langer
2022-07-26
Billions of Research Dollars May Have Been Wasted Due to Fraudulent Alzheimer’s Study
2022-07-26
Cancer Research UK and Sosei Heptares Set for First Human Trial of EP4 Antagonist
2022-07-22
Pfizer and Flynn Fined £70 Million in Epilepsy Drug Price Hike Scheme
2022-07-22
Shifting From Counterculture to Clinical Applications, The Problems Psychedelics Face Getting to Market
2022-07-22
Takeda Throws $1 Million at F-star to Develop Bispecific Antibody For Novel Cancer Therapies
2022-07-21
Roche Offers Up to $1 Billion for Avista to Develop Eye Disease Vectors
2022-07-20
A New Liquid Take On an Old Epilepsy Drug Receives FDA Approval
2022-07-19
1 … 8 9 10 11 12 … 15
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top